Mirum Pharmaceuticals, Inc. MIRM Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s investment purchases?
- Mirum Pharmaceuticals, Inc. (MIRM) reported investment purchases of $34.8M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s investment purchases changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s investment purchases increased by 3.8% year-over-year, from $33.53M to $34.8M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s investment purchases?
- Over 3 years (2021 to 2025), Mirum Pharmaceuticals, Inc.'s investment purchases has grown at a -21.1% compound annual growth rate (CAGR), from $198.03M to $97.43M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.